JCIA
CPRX

Jackson Creek Investment Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History

Jackson Creek Investment Advisors’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.91M Buy
77,304
+57,480
+290% +$1.37M 0.56% 42
2025
Q4 		$463K Buy
+19,824
New +$442K 0.14% 211
2025
Q3 		– Sell
-19,295
Closed -$419K – 291
2025
Q2 		$419K Sell
19,295
-9,989
-34% -$236K 0.11% 252
2025
Q1 		$710K Sell
29,284
-42,465
-59% -$956K 0.23% 202
2024
Q4 		$1.5M Sell
71,749
-2,220
-3% -$47.7K 0.45% 101
2024
Q3 		$1.47M Buy
+73,969
New +$1.37M 0.44% 123
2024
Q1 		– Sell
-68,203
Closed -$1.15M – 313
2023
Q4 		$1.15M Sell
68,203
-7
-0% -$96 0.44% 56
2023
Q3 		$797K Buy
+68,210
New +$912K 0.34% 160
2023
Q2 		– Sell
-45,033
Closed -$747K – 316
2023
Q1 		$747K Sell
45,033
-24,300
-35% -$401K 0.31% 177
2022
Q4 		$1.29M Sell
69,333
-2,605
-4% -$40.1K 0.57% 8
2022
Q3 		$923K Sell
71,938
-55,565
-44% -$659K 0.43% 65
2022
Q2 		$1.31M Sell
127,503
-10,436
-8% -$76.5K 0.53% 12
2022
Q1 		$1.14M Buy
+137,939
New +$975K 0.42% 85

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Jackson Creek Investment Advisors's CPRX Position: Q1 2026 in Review

Jackson Creek Investment Advisors increased its Catalyst Pharmaceutical (CPRX) stake by 290% in Q1 2026, buying an estimated $1.37M and bringing the position to 77,304 shares worth $1.91M. The position accounts for 0.56% of the portfolio, ranked #42.

Jackson Creek Investment Advisors first reported a position in CPRX in Q1 2022 and has held it in 13 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Jackson Creek Investment Advisors held 77,304 shares of Catalyst Pharmaceutical worth $1.91M as of Q1 2026.
  • Jackson Creek Investment Advisors bought 57,480 Catalyst Pharmaceutical shares in Q1 2026, an estimated $1.37M.
  • Catalyst Pharmaceutical made up 0.56% of Jackson Creek Investment Advisors's portfolio in Q1 2026, its #42 holding.
  • Jackson Creek Investment Advisors first reported a position in Catalyst Pharmaceutical in Q1 2022 and has held it in 13 quarters since.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q1 2026, filed 5 May 2026.